2021 Q2 Form 10-Q Financial Statement

#000155837021011605 Filed on August 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $20.77K
YoY Change
Cost Of Revenue $12.35K
YoY Change
Gross Profit $8.422K
YoY Change
Gross Profit Margin 40.55%
Selling, General & Admin $1.345M $242.8K $526.1K
YoY Change 454.01%
% of Gross Profit 6246.87%
Research & Development $1.355M $999.0K $1.112M
YoY Change 35.64%
% of Gross Profit 13199.39%
Depreciation & Amortization $50.16K
YoY Change
% of Gross Profit 595.52%
Operating Expenses $2.716M $1.242M $1.638M
YoY Change 118.72%
Operating Profit -$2.460M -$1.056M -$1.437M
YoY Change 133.03%
Interest Expense $6.835M
YoY Change
% of Operating Profit
Other Income/Expense, Net $59.00K $1.375K -$18.59M
YoY Change 4190.91%
Pretax Income -$2.401M -$1.054M -$20.02M
YoY Change 127.74%
Income Tax
% Of Pretax Income
Net Earnings -$2.401M -$1.054M -$20.02M
YoY Change 127.74%
Net Earnings / Revenue -96408.21%
Basic Earnings Per Share -$0.09
Diluted Earnings Per Share -$0.09
COMMON SHARES
Basic Shares Outstanding 27.07M
Diluted Shares Outstanding 27.07M 116.1K

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $16.40M $1.570M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $19.13M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $715.1K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.574K
YoY Change
Total Long-Term Assets $956.6K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $19.13M
Total Long-Term Assets $956.6K
Total Assets $20.08M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $475.6K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.484M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.484M
Total Long-Term Liabilities
Total Liabilities $1.518M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$69.70M
YoY Change
Common Stock $2.547K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $18.56M $3.316M $4.392M
YoY Change
Total Liabilities & Shareholders Equity $20.08M
YoY Change

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income -$2.401M -$1.054M -$20.02M
YoY Change 127.74%
Depreciation, Depletion And Amortization $50.16K
YoY Change
Cash From Operating Activities $1.617M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $14.99K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$14.99K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.279M
YoY Change
NET CHANGE
Cash From Operating Activities 1.617M
Cash From Investing Activities -14.99K
Cash From Financing Activities 4.279M
Net Change In Cash 2.647M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $1.617M
Capital Expenditures $14.99K
Free Cash Flow $1.602M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56181
dei Entity Registrant Name
EntityRegistrantName
SmartKem, Inc.
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13627887
dei Entity Central Index Key
EntityCentralIndexKey
0001817760
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25462000
CY2021Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2020Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
CY2021Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1083654
CY2021Q2 cik0001817760 Utilities Expense
UtilitiesExpense
943
CY2020Q2 cik0001817760 Utilities Expense
UtilitiesExpense
-1683
cik0001817760 Utilities Expense
UtilitiesExpense
1593
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20475
CY2021Q2 us-gaap Liabilities
Liabilities
1517904
dei Entity Address Address Line1
EntityAddressAddressLine1
Manchester Technology Centre, Hexagon Tower.
dei Entity Address Address Line2
EntityAddressAddressLine2
Delaunays Road
dei Entity Address Address Line3
EntityAddressAddressLine3
Blackley
dei Entity Address City Or Town
EntityAddressCityOrTown
Manchester
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
M9 8GQ
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
X0
dei City Area Code
CityAreaCode
011-44-161
dei Local Phone Number
LocalPhoneNumber
721-1514
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25462000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16430719
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
763814
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
18385
CY2021Q2 cik0001817760 Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
1490253
CY2020Q4 cik0001817760 Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
981568
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1204262
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
259046
CY2021Q2 us-gaap Assets Current
AssetsCurrent
19125234
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2022813
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1014063
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
908238
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
715068
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
682325
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
231967
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
236123
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9574
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8408
CY2021Q2 us-gaap Assets
Assets
20081843
CY2020Q4 us-gaap Assets
Assets
2949669
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1307662
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
860633
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
176694
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
217313
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1484356
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1077946
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33548
CY2020Q4 us-gaap Liabilities
Liabilities
1098421
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25462000
CY2020Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
148
CY2020Q2 us-gaap Interest Income Other
InterestIncomeOther
1227
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13627887
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
2547
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1363
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89721913
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
61275841
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1447191
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1479841
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69713330
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57946115
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
18563939
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1851248
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20081843
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2949669
us-gaap Revenues
Revenues
20770
us-gaap Cost Of Revenue
CostOfRevenue
12348
us-gaap Gross Profit
GrossProfit
8422
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
255648
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
186119
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
688171
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
377996
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1355167
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
998985
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5368511
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2110638
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1345248
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
242776
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5328073
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
768887
CY2021Q2 cik0001817760 Transaction Expenses
TransactionExpenses
15232
cik0001817760 Transaction Expenses
TransactionExpenses
1329271
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
2715647
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
1241761
us-gaap Operating Expenses
OperatingExpenses
12025855
us-gaap Operating Expenses
OperatingExpenses
2879525
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2459999
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1055642
us-gaap Operating Income Loss
OperatingIncomeLoss
-11337684
us-gaap Operating Income Loss
OperatingIncomeLoss
-2493107
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
57230
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-412853
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1418
us-gaap Interest Expense
InterestExpense
18697
us-gaap Interest Expense
InterestExpense
6834772
CY2021Q2 us-gaap Interest Income Other
InterestIncomeOther
1869
us-gaap Interest Income Other
InterestIncomeOther
2019
us-gaap Interest Income Other
InterestIncomeOther
3251
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-6282381
cik0001817760 Loss On Conversion Of Convertible Notes Payable
LossOnConversionOfConvertibleNotesPayable
5469825
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
59099
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-21866
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1054267
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
3315548
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1851248
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19543
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6019517
CY2021Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
99000
CY2021Q1 cik0001817760 Stock Issued During Period Value New Shares And Warrants Issued
StockIssuedDuringPeriodValueNewSharesAndWarrantsIssued
24638320
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1375
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-429531
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-18585145
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2400900
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1054267
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11767215
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21078252
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2400900
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1054267
us-gaap Net Income Loss
NetIncomeLoss
-11767215
us-gaap Net Income Loss
NetIncomeLoss
-21078252
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2400900
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1054267
us-gaap Net Income Loss
NetIncomeLoss
-11767215
us-gaap Net Income Loss
NetIncomeLoss
-21078252
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15170
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-21866
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
32650
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-561353
CY2021Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2385730
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1076133
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-11734565
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-21639605
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.52
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.80
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27066385
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13447057
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
22733033
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
12022647
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-5082435
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4278930
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
25758658
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-539487
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-20023985
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
4391681
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2454324
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
17480
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-9366315
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
20824468
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
75201
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
50000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
15170
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2400900
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
18563939
us-gaap Profit Loss
ProfitLoss
-11767215
us-gaap Profit Loss
ProfitLoss
-21078252
us-gaap Depreciation
Depreciation
95188
us-gaap Depreciation
Depreciation
98494
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
107333
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
96135
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
88444
us-gaap Share Based Compensation
ShareBasedCompensation
6094718
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-6834772
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-6282381
cik0001817760 Loss On Conversion Of Convertible Notes Payable
LossOnConversionOfConvertibleNotesPayable
5469825
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18562
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
545
cik0001817760 Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
498909
cik0001817760 Increase Decrease In Research And Development Tax Credit Receivable
IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable
366162
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
901044
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
44037
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
435473
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-41077
cik0001817760 Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-119709
cik0001817760 Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-79201
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1069
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6440537
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2835358
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
120568
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88359
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-120568
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-88359
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
737898
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
737898
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4278930
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
24638320
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2454324
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19543
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22203539
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4278930
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
24471
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-197110
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15642434
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1355213
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
763814
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
411936
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16430719
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1570039
us-gaap Interest Paid Net
InterestPaidNet
18697
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
86357
us-gaap Stock Issued1
StockIssued1
50000
cik0001817760 Debt Conversion And Accrued Interest Into Common Shares
DebtConversionAndAccruedInterestIntoCommonShares
25758658
CY2021Q2 cik0001817760 Number Of Issued Patents
NumberOfIssuedPatents
124
CY2021Q2 cik0001817760 Number Of Pending Patent Applications
NumberOfPendingPatentApplications
11
CY2021Q2 cik0001817760 Number Of Future National Applications
NumberOfFutureNationalApplications
25
CY2021Q2 cik0001817760 Number Of Trade Secrets
NumberOfTradeSecrets
30
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2400000
us-gaap Net Income Loss
NetIncomeLoss
-11800000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6400000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-69700000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16400000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Management’s Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of condensed consolidated financial statements in conformity U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and liabilities, at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The most significant estimates in the Company’s condensed consolidated financial statements relates to the valuation of common share, fair value of share options, fair value of embedded conversion features in the convertible notes, and the valuation allowance of deferred tax assets. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Due to the uncertainty of factors surrounding the estimates or judgments used in the preparation of the financial statements, actual results may materially vary from these estimates. </p>
CY2021Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q2 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
0
CY2020Q4 us-gaap Allowance For Doubtful Other Receivables Current
AllowanceForDoubtfulOtherReceivablesCurrent
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Concentrations of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to significant concentration of credit risk consist primarily of cash and cash equivalents and accounts receivable. Periodically, the Company maintains deposits in financial institutions in excess of government insured limits. Management believes that the Company is not exposed to significant credit risk as the Company’s deposits are held at financial institutions that management believes to be of high credit quality and the Company has not experienced any losses in these deposits.</p>
CY2021Q2 us-gaap Property Plant And Equipment Salvage Value Percentage
PropertyPlantAndEquipmentSalvageValuePercentage
0.25
us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P15Y
us-gaap Derivatives Embedded Derivatives
DerivativesEmbeddedDerivatives
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Derivative Asset for Embedded Conversion Features</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company evaluates convertible notes to determine if those contracts or embedded components of those contracts qualify as derivatives to be accounted for separately. In circumstances where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for as a single, compound derivative instrument. The result of this accounting treatment is that the fair value of the embedded derivative is recorded as a liability and marked-to-market each balance sheet date, with the change in fair value recorded in the statements of operations as other income or expense. Upon conversion or exercise of a derivative instrument, the instrument is marked to fair value at the conversion date and then that fair value is reclassified to equity.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The fair value of the embedded conversion features are estimated using a Monte Carlo simulation model, in which possible outcomes and their values are simulated repeatedly and randomly. Under the Monte Carlo method the Company estimated the fair value of the convertible notes conversion feature at the time of issuance and subsequent remeasurement dates, utilizing the with-and without method, where the value of the derivative feature is the difference in values between a note simulated with the embedded conversion feature and the value of the same note simulated without the embedded conversion feature. Estimating fair values of embedded conversion features requires the development of significant and subjective estimates that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors.</p>
CY2021Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
255648
CY2020Q2 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
186119
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
688171
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
377996
CY2021Q2 cik0001817760 Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
1490253
CY2020Q4 cik0001817760 Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
981568
CY2021Q2 us-gaap Prepaid Rent
PrepaidRent
93585
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2021Q2 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2020Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2454324
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2582095
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
116084
CY2020Q4 us-gaap Prepaid Rent
PrepaidRent
65254
CY2021Q2 cik0001817760 Prepaid Utilities
PrepaidUtilities
30639
CY2020Q4 cik0001817760 Prepaid Utilities
PrepaidUtilities
30271
CY2021Q2 us-gaap Prepaid Insurance
PrepaidInsurance
674771
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
40414
CY2021Q2 cik0001817760 Prepaid Administrative Expenses
PrepaidAdministrativeExpenses
92517
CY2020Q4 cik0001817760 Prepaid Administrative Expenses
PrepaidAdministrativeExpenses
68901
CY2021Q2 cik0001817760 Prepaid Consulting Fees
PrepaidConsultingFees
124581
CY2021Q2 us-gaap Prepaid Taxes
PrepaidTaxes
75847
CY2020Q4 us-gaap Prepaid Taxes
PrepaidTaxes
54206
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1590563
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1014063
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
908238
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
715068
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
682325
CY2021Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
112322
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1204262
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
259046
CY2021Q2 cik0001817760 Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
239531
CY2020Q4 cik0001817760 Prepaid Insurance Noncurrent
PrepaidInsuranceNoncurrent
0
CY2020Q4 cik0001817760 Accrued Liabilities Current Lab Refurbishment
AccruedLiabilitiesCurrentLabRefurbishment
132356
CY2021Q2 cik0001817760 Accrued Technical Costs Current
AccruedTechnicalCostsCurrent
88008
CY2020Q4 cik0001817760 Accrued Technical Costs Current
AccruedTechnicalCostsCurrent
44755
CY2021Q2 cik0001817760 Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
12848
CY2020Q4 cik0001817760 Accrued Rent And Utilities Current
AccruedRentAndUtilitiesCurrent
67165
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1729131
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
475645
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
226850
CY2021Q2 cik0001817760 Accrued Liabilities Current Transaction Cost
AccruedLiabilitiesCurrentTransactionCost
68755
CY2021Q2 cik0001817760 Accrued Liabilities Current Lab Refurbishment
AccruedLiabilitiesCurrentLabRefurbishment
147667
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
159973
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
20475
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
210242
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
237788
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
250437
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
30432
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5879
CY2021Q2 cik0001817760 Accrued Credit Card Liabilities Current
AccruedCreditCardLiabilitiesCurrent
14054
CY2020Q4 cik0001817760 Accrued Credit Card Liabilities Current
AccruedCreditCardLiabilitiesCurrent
6308
CY2021Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
310280
CY2020Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
126883
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1307662
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
860633
us-gaap Sublease Income
SubleaseIncome
0
CY2020Q2 us-gaap Sublease Income
SubleaseIncome
0
us-gaap Sublease Income
SubleaseIncome
0
CY2021Q2 us-gaap Sublease Income
SubleaseIncome
0
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
52121
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
42850
us-gaap Operating Lease Cost
OperatingLeaseCost
99192
us-gaap Operating Lease Cost
OperatingLeaseCost
87025
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
12611
CY2020Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
2014
us-gaap Short Term Lease Cost
ShortTermLeaseCost
25947
us-gaap Short Term Lease Cost
ShortTermLeaseCost
13111
CY2021Q2 us-gaap Variable Lease Cost
VariableLeaseCost
63734
CY2020Q2 us-gaap Variable Lease Cost
VariableLeaseCost
71425
us-gaap Variable Lease Cost
VariableLeaseCost
97544
us-gaap Variable Lease Cost
VariableLeaseCost
125508
CY2021Q2 us-gaap Lease Cost
LeaseCost
128466
CY2020Q2 us-gaap Lease Cost
LeaseCost
116289
us-gaap Lease Cost
LeaseCost
222683
us-gaap Lease Cost
LeaseCost
225644
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
231967
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
236123
CY2021Q2 cik0001817760 Operating Lease Assets Including Lease Assets Held For Sale
OperatingLeaseAssetsIncludingLeaseAssetsHeldForSale
231967
CY2020Q4 cik0001817760 Operating Lease Assets Including Lease Assets Held For Sale
OperatingLeaseAssetsIncludingLeaseAssetsHeldForSale
236123
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
176694
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
217313
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33548
CY2020Q1 cik0001817760 Debt Conversion Converted Instrument Interest Accrued Amount
DebtConversionConvertedInstrumentInterestAccruedAmount
1062725
CY2020Q1 cik0001817760 Debt Conversion Converted Instrument Interest Accrued Shares Issued
DebtConversionConvertedInstrumentInterestAccruedSharesIssued
735148
CY2020Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.45
cik0001817760 Loss On Conversion Of Convertible Notes Payable
LossOnConversionOfConvertibleNotesPayable
5469825
CY2021Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0
CY2020Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0
us-gaap Operating Lease Payments
OperatingLeasePayments
119709
us-gaap Operating Lease Payments
OperatingLeasePayments
79201
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
86357
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y1M6D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0612
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
145860
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
73429
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8571
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
227860
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
17618
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
210242
CY2020Q1 cik0001817760 Cumulative Investment Proceeds From Common Stock Threshold Limit
CumulativeInvestmentProceedsFromCommonStockThresholdLimit
4600000
CY2020Q1 us-gaap Share Price
SharePrice
1.807011
CY2020Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
11795998
CY2020Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
8159977
CY2020Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.45
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
6767178
CY2020Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.135
CY2020Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0
CY2021Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0
CY2021Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0
cik0001817760 Debt Instrument Increase Accrued Interest Expense Based On Stated Interest Rate
DebtInstrumentIncreaseAccruedInterestExpenseBasedOnStatedInterestRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
cik0001817760 Debt Instrument Increase Accrued Interest Expense Based On Stated Interest Rate
DebtInstrumentIncreaseAccruedInterestExpenseBasedOnStatedInterestRate
42784
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
24810
CY2020Q2 cik0001817760 Debt Instrument Increase Accrued Interest Expense Based On Stated Interest Rate
DebtInstrumentIncreaseAccruedInterestExpenseBasedOnStatedInterestRate
0
CY2021Q2 cik0001817760 Debt Instrument Increase Accrued Interest Expense Based On Stated Interest Rate
DebtInstrumentIncreaseAccruedInterestExpenseBasedOnStatedInterestRate
0
CY2020Q2 cik0001817760 Loss On Conversion Of Convertible Notes Payable
LossOnConversionOfConvertibleNotesPayable
9343697
CY2020Q2 cik0001817760 Gain Loss On Conversion Of Accrued Interest On Convertible Notes Payable
GainLossOnConversionOfAccruedInterestOnConvertibleNotesPayable
1046085
CY2020Q2 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
4919957
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
6282381
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
4919957
CY2021Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0
CY2021Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
0
CY2021Q2 us-gaap Derivative Assets
DerivativeAssets
0
cik0001817760 Common Stock Number Of Votes Per Share
CommonStockNumberOfVotesPerShare
1
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
10000000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.005
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.012
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1810749
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.06143
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y8M12D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
3.46867
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1404813
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.01466
cik0001817760 Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Cancelled Number Of Shares
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsCancelledNumberOfShares
-405936
cik0001817760 Share Based Compensation Arrangements By Share Based Payment Award Options Cancellation In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancellationInPeriodWeightedAverageExercisePrice
0.06452
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1596562
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.57861
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
1596562
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.57861
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y8M23D
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.22084
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.22
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
402586
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
75201
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6094718
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1147842
CY2021Q2 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
489122
CY2020Q2 us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
182871
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
4216562
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
473041
CY2021Q2 cik0001817760 Rent Expense
RentExpense
2763
CY2020Q2 cik0001817760 Rent Expense
RentExpense
3467
cik0001817760 Rent Expense
RentExpense
16008
cik0001817760 Rent Expense
RentExpense
20775
CY2021Q2 us-gaap General Insurance Expense
GeneralInsuranceExpense
154875
us-gaap General Insurance Expense
GeneralInsuranceExpense
154875
cik0001817760 Utilities Expense
UtilitiesExpense
-1316
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
83168
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10454
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
105098
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
33767
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
558543
CY2020Q2 us-gaap Professional Fees
ProfessionalFees
47147
us-gaap Professional Fees
ProfessionalFees
708111
us-gaap Professional Fees
ProfessionalFees
230244
CY2021Q2 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
55834
CY2020Q2 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
520
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
125826
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
12376
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1345248
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
242776
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5328073
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
768887
CY2021Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
33263
CY2020Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
15377
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
64737
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
41264
CY2021Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
33263
CY2020Q2 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
15377
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
64737
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
41264
CY2021Q2 cik0001817760 Defined Contribution Plan Due To Pension Fund
DefinedContributionPlanDueToPensionFund
0
CY2020Q4 cik0001817760 Defined Contribution Plan Due To Pension Fund
DefinedContributionPlanDueToPensionFund
0

Files In Submission

Name View Source Status
0001558370-21-011605-index-headers.html Edgar Link pending
0001558370-21-011605-index.html Edgar Link pending
0001558370-21-011605.txt Edgar Link pending
0001558370-21-011605-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmb-20210630.xsd Edgar Link pending
tmb-20210630x10q.htm Edgar Link pending
tmb-20210630x10q_htm.xml Edgar Link completed
tmb-20210630xex31d1.htm Edgar Link pending
tmb-20210630xex31d2.htm Edgar Link pending
tmb-20210630xex32d1.htm Edgar Link pending
tmb-20210630xex32d2.htm Edgar Link pending
tmb-20210630_cal.xml Edgar Link unprocessable
tmb-20210630_def.xml Edgar Link unprocessable
tmb-20210630_lab.xml Edgar Link unprocessable
tmb-20210630_pre.xml Edgar Link unprocessable